HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seung Hyun Kim Selected Research

JPI-289

9/2018Early Treatment with Poly(ADP-Ribose) Polymerase-1 Inhibitor (JPI-289) Reduces Infarct Volume and Improves Long-Term Behavior in an Animal Model of Ischemic Stroke.
7/2018Regulatory T cells increase after treatment with poly (ADP-ribose) polymerase-1 inhibitor in ischemic stroke patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seung Hyun Kim Research Topics

Disease

28Neoplasms (Cancer)
10/2022 - 10/2002
25Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2022 - 07/2005
14Alzheimer Disease (Alzheimer's Disease)
10/2021 - 07/2005
14Leukemia
10/2020 - 10/2002
13Neurodegenerative Diseases (Neurodegenerative Disease)
11/2018 - 07/2005
11Inflammation (Inflammations)
08/2021 - 09/2004
11Ischemic Stroke
09/2018 - 09/2004
8Infections
07/2022 - 03/2014
7Disease Progression
11/2020 - 03/2006
5Postoperative Nausea and Vomiting (PONV)
05/2022 - 01/2018
5Asthma (Bronchial Asthma)
01/2021 - 04/2011
5Osteosarcoma (Osteogenic Sarcoma)
06/2017 - 09/2014
5Neoplasm Metastasis (Metastasis)
06/2017 - 11/2009
5Body Weight (Weight, Body)
11/2012 - 07/2003
5Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2009 - 12/2007
4Sarcoma (Soft Tissue Sarcoma)
01/2022 - 01/2019
4Infarction (Infarctions)
09/2018 - 09/2004
4Stroke (Strokes)
09/2018 - 01/2006
4Hypoxia (Hypoxemia)
01/2018 - 08/2003
4Acute Promyelocytic Leukemia
03/2014 - 10/2006
4Amnesia (Dissociative Amnesia)
11/2012 - 07/2003
4Hypersensitivity (Allergy)
08/2012 - 08/2005
4Myeloid Leukemia (Leukemia, Myelocytic)
02/2008 - 10/2002
3Hypotension (Low Blood Pressure)
01/2022 - 01/2014
3Neuroinflammatory Diseases
01/2022 - 09/2018
3Postoperative Pain
01/2022 - 05/2017
3Breast Neoplasms (Breast Cancer)
12/2021 - 11/2009
3Atopic Dermatitis (Atopic Eczema)
08/2021 - 11/2017
3Demyelinating Diseases (Demyelinating Disease)
01/2021 - 11/2016
3Pain (Aches)
01/2018 - 05/2017
3Wounds and Injuries (Trauma)
07/2014 - 09/2011
3Parkinson Disease (Parkinson's Disease)
11/2009 - 05/2008
3Thymoma (Thymic Carcinoma)
10/2008 - 03/2006
2Intracranial Hemorrhages (Intracranial Hemorrhage)
02/2022 - 01/2015
2Hemorrhage
01/2022 - 11/2020
2Liposarcoma
01/2022 - 01/2020
2Mitochondrial Diseases (Mitochondrial Disease)
01/2022 - 11/2009
2Leiomyosarcoma
01/2022 - 01/2019
2Ischemia
01/2022 - 01/2018
2Hemangiosarcoma (Angiosarcoma)
03/2021 - 01/2019
2Obesity
01/2021 - 06/2013
2Genetic Predisposition to Disease (Genetic Predisposition)
01/2021 - 01/2016
2Frontotemporal Dementia (Semantic Dementia)
01/2021 - 05/2014
2Nausea
01/2021 - 01/2018
2Emergence Delirium
11/2020 - 05/2017

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2003
9Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2014
9Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2014 - 10/2002
8Neuroprotective AgentsIBA
09/2018 - 03/2006
7Pharmaceutical PreparationsIBA
01/2019 - 04/2008
6Glycogen Synthase (Synthase I)IBA
01/2017 - 09/2004
5Antiviral Agents (Antivirals)IBA
07/2022 - 02/2015
5Amyloid (Amyloid Fibrils)IBA
10/2021 - 12/2010
5AllergensIBA
01/2021 - 08/2005
5DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2003
5Scopolamine (Hyoscine)FDA Link
11/2012 - 07/2003
4AntiemeticsIBA
01/2021 - 01/2018
4Phosphotransferases (Kinase)IBA
01/2019 - 05/2006
4CytokinesIBA
07/2018 - 05/2006
4Immunoglobulin E (IgE)IBA
01/2017 - 04/2006
41,25-dihydroxyvitamin DIBA
12/2007 - 08/2003
3Amyloid beta-PeptidesIBA
01/2022 - 01/2008
3Analgesics (Analgesic Drugs)IBA
01/2022 - 05/2017
3Opioid Analgesics (Opioids)IBA
01/2021 - 05/2017
3SphingosineIBA
12/2020 - 01/2018
3AntioxidantsIBA
04/2019 - 04/2014
3Alkaline PhosphataseIBA
06/2017 - 09/2014
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2016 - 09/2004
3Caspase 3 (Caspase-3)IBA
04/2016 - 09/2004
3Superoxide Dismutase-1IBA
10/2015 - 07/2005
3Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2015 - 10/2005
3ErythropoietinFDA Link
10/2014 - 09/2010
3SesquiterpenesIBA
03/2014 - 10/2002
3Levodopa (L Dopa)FDA LinkGeneric
11/2009 - 05/2008
3Interleukin-4 (Interleukin 4)IBA
05/2006 - 03/2006
2RNA (Ribonucleic Acid)IBA
10/2022 - 08/2003
2Indicators and Reagents (Reagents)IBA
10/2022 - 01/2021
2salicylhydroxamic acid (SHAM)IBA
05/2022 - 01/2018
2GemcitabineFDA Link
01/2022 - 01/2019
2Biological ProductsIBA
12/2021 - 02/2013
2Leukocyte L1 Antigen Complex (Calgranulin)IBA
08/2021 - 01/2018
2pazopanibFDA Link
03/2021 - 01/2019
2Propofol (Diprivan)FDA LinkGeneric
01/2021 - 04/2019
2GoldIBA
12/2020 - 12/2019
2Hypnotics and Sedatives (Sedatives)IBA
11/2020 - 01/2018
2Growth Hormone (Somatotropin)IBA
11/2020 - 04/2019

Therapy/Procedure

18Therapeutics
01/2022 - 10/2002
6Anesthesia
01/2022 - 01/2018
6Traditional Medicine (Folk Remedies)
01/2021 - 05/2017
4General Anesthesia
01/2022 - 01/2018
4Neoadjuvant Therapy
06/2017 - 09/2014
3Precision Medicine
01/2020 - 01/2018
3Aftercare (After-Treatment)
04/2019 - 10/2012
2Craniotomy
02/2022 - 07/2020
2Analgesia
01/2022 - 01/2018
2Length of Stay
01/2022 - 01/2020
2Radiotherapy
12/2021 - 01/2018
2Oral Administration
08/2021 - 01/2009
2Patient-Controlled Analgesia (Analgesia, Patient Controlled)
01/2021 - 01/2018
2Cesarean Section (Caesarean Section)
01/2021 - 02/2017